Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
47,723,194
-
Share change
-
+20,958,010
-
Total reported value
-
$71,103,902
-
Put/Call ratio
-
2.2%
-
Price per share
-
$1.49
-
Number of holders
-
47
-
Value change
-
+$31,154,220
-
Number of buys
-
22
-
Number of sells
-
18
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q4 2022
As of 31 Dec 2022,
RECRO PHARMA INC - COM (SCTL) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,723,194 shares.
The largest 10 holders included
AWM Investment Company, Inc., First Light Asset Management, LLC, Cowen Prime Advisors LLC, Samjo Capital LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, Athyrium Capital Management, LP, ROYCE & ASSOCIATES LP, and Caligan Partners LP.
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.